Physician profile
Mind-Da Le
NPI 1336502749
$5,223.73
in general payments reported to CMS, 2019-2025
36 companies · $2,263 in 2025
The $2,263 reported for 2025 was more than what 79% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $232 · 2023: $1,223 · 2024: $1,505 · 2025: $2,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,988 · Education: $4.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,987.70 |
| Education | $4.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $646.47 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $515.68 | 2023-2025 | Jardiance |
| Radius Health, INC. | $347.28 | 2022-2025 | Tymlos |
| Xeris Pharmaceuticals, INC. | $339.30 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Corcept Therapeutics | $327.52 | 2024-2025 | Korlym |
| Dexcom, INC. | $298.79 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $251.85 | 2023-2025 | |
| Amgen INC. | $195.92 | 2025 | Evenity, Tepezza |
| Antares Pharma, INC. | $194.14 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Neurocrine Biosciences, INC. | $154.90 | 2024-2025 | Crenessity |
| Tandem Diabetes Care, INC. | $147.03 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $146.87 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Beta Bionics, INC. | $146.53 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Averitas Pharma INC. | $139.49 | 2023-2025 | Qutenza |
| Abbott Laboratories | $131.37 | 2023-2025 | Freestyle Libre 3 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $130.42 | 2025 | Yorvipath |
| Bayer Healthcare Pharmaceuticals INC. | $124.72 | 2022 | |
| Amneal Pharmaceuticals LLC | $119.02 | 2023-2025 | Unithroid |
| Kyowa Kirin, INC. | $107.88 | 2023-2025 | Crysvita |
| Ibsa Pharma INC. | $102.10 | 2023-2025 | Licart, Tirosint, Flector |
| Pfizer INC. | $98.34 | 2023-2025 | |
| Mannkind Corporation | $90.66 | 2023-2025 | Afrezza |
| Avvisto Therapeutics, LLC | $59.19 | 2024-2025 | Cycloset |
| Madrigal Pharmaceuticals | $50.24 | 2025 | Rezdiffra |
| Medtronic, INC. | $47.72 | 2022-2025 | Minimed 780g |
| Halozyme INC | $45.25 | 2023 | |
| Abbvie INC. | $44.34 | 2023-2025 | |
| Sequel Med Tech, LLC | $39.19 | 2025 | Twiist |
| Insulet Corporation | $37.19 | 2023-2024 | Omnipod |
| Soleno Therapeutics, INC. | $29.56 | 2025 | Vykat Xr |
| Rhythm Pharmaceuticals, INC. | $24.50 | 2025 | Imcivree |
| Embecta Corp. | $21.11 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Alvogen INC | $19.71 | 2023 | Teriparatide |
| Alexion Pharmaceuticals, INC. | $18.92 | 2025 | Strensiq |
| Tolmar, INC. | $16.08 | 2025 | Jatenzo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.45 | 2023 | Cycloset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mind-Da Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.